Skip to content

SmallCap Round Up: Cleantech Lithium, Cadence Minerals, Arbuthnot Banking


The AIM Index managed to post some modest gains on Tuesday, advancing a further four points to close at 753.53. Over the last week, the all share has added a respectable 2% as recession and rate hike fears from the US both cool.

  • Cleantech Lithium +23%
  • Cadence Minerals +22%
  • Arbuthnot Banking +18%
  • Bonhill Group -54%
  • Pelatro -49%

Cleantech Lithium [LON:CTL] topped the board on Tuesday, adding 23%. Yesterday the company provided an upgraded JORC resource estimate, but the news failed to deliver any tailwind for the share price. Investors appear to have caught up today with a meaningful uptick in volumes and the stock returning briefly to levels not seen in almost three months.

Cadence Minerals [LON:KDNC] was in second place, around 22% higher by the bell. The stock saw some significantly elevated volumes on the day although there’s no news out to directly support the news. However with a strong portfolio of assets there are some suggestions that this could be undervalued.

Arbuthnot Banking [LON:ARBB] gets the notable mention, up 18% following the release of interim results. The bank has received a significant boost off higher interest rates although cautions that funding costs will increase in the second half of the year as longer term deposit instruments expire.

Bonhill Group [LON:BONH] was on the radar again, this time as the day’s biggest faller off 54% by the bell. There’s no fresh news out but as noted yesterday the directors are pursuing a members’ voluntary liquidation.  Trade was thin with buyers proving elusive.

Pelatro [LON:PTRO] dipped 49%  following a trading update. The company flagged unusual delays in collection of receivables owing to some cross-border issues, Whilst these should have perhaps been guarded against ahead of time, the most worrying point is likely the fact management have flagged that additional funding may be required in the final quarter of the year.

Like this article? Sign up to our free newsletter.

This article does not constitute investment advice. Do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
CME Group
Back To Top